FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Lupin Somerset Fluocinolone Acetonide Topical Solution Recall

Fluocinolone Acetonide Topical Solution, USP, 0

LUPIN SOMERSET · Somerset, NJ

Risk level
Class II
Reported by FDA
Jan 30, 2019
Recall ID
D-0390-2019
Check your lot numberHow we source this data

Summary

Lupin Somerset recalled Fluocinolone Acetonide Topical Solution starting Jan 15, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0390-2019 on Jan 30, 2019. Reason: Failed Impurities/Degradation Specifications: Expansion of October 2018 recall due to elevated out of specification results for total impurities that have been chemically identified as oxidative degradation products of the fluocinolone active pharmaceutical ingredient. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Expansion of October 2018 recall due to elevated out of specification results for total impurities that have been chemically identified as oxidative degradation products of the fluocinolone active pharmaceutical ingredient.

Product description

Fluocinolone Acetonide Topical Solution, USP, 0.01 %, 60 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202; Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873; NDC 43386-069-60.

Lot numbers, UPCs & expiration codes

Lot #: S700214, Exp Apr-19; S700447, Exp Jun-19; S700787, Exp Oct-19; S701057, Exp Nov-19; S800107, Exp Feb-20; S800266, Exp Mar-20; S800524, Exp May-20; S800791, Exp Jul-20

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0390-2019
Classification
Class II
Status
Terminated
Recall initiated
Jan 15, 2019
FDA report date
Jan 30, 2019
Quantity
24,180 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
LUPIN SOMERSET

Original FDA data

Every field from FDA enforcement report D-0390-2019, exactly as published.

Show all FDA fields
City
Somerset
State
NJ
Status
Terminated
Country
United States
Event ID
81925
Address
400 Campus Dr
Code information
Lot #: S700214, Exp Apr-19; S700447, Exp Jun-19; S700787, Exp Oct-19; S701057, Exp Nov-19; S800107, Exp Feb-20; S800266, Exp Mar-20; S800524, Exp May-20; S800791, Exp Jul-20
Postal code
08873-1145
Report date
Jan 30, 2019
Product type
Drugs
Recall number
D-0390-2019
Classification
Class II
Recalling firm
LUPIN SOMERSET
Product quantity
24,180 bottles
Termination date
Feb 17, 2023
Reason for recall
Failed Impurities/Degradation Specifications: Expansion of October 2018 recall due to elevated out of specification results for total impurities that have been chemically identified as oxidative degradation products of the fluocinolone active pharmaceutical ingredient.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fluocinolone Acetonide Topical Solution, USP, 0.01 %, 60 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202; Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873; NDC 43386-069-60.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Jan 15, 2019
Initial firm notification
Letter
Center classification date
Jan 23, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0390-2019, published Jan 30, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls